Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry.
作者信息
Humphreys Keith, Shover Chelsea L
机构信息
Veterans Affairs Health Care System, Palo Alto, CA, USA.
Stanford University School of Medicine, Stanford, CA, USA.
出版信息
World Psychiatry. 2020 Jun;19(2):191-192. doi: 10.1002/wps.20739.
Abstract
摘要
相似文献
1
Recreational cannabis legalization presents an opportunity to reduce the harms of the US medical cannabis industry.休闲大麻合法化提供了一个减少美国医用大麻行业危害的机会。
World Psychiatry. 2020 Jun;19(2):191-192. doi: 10.1002/wps.20739.
2
Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia.澳大利亚对医用和消遣用大麻合法化支持的个人相关因素。
Front Psychiatry. 2021 Feb 25;12:551661. doi: 10.3389/fpsyt.2021.551661. eCollection 2021.
3
The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.娱乐用大麻获取途径合法化对加拿大癌症医用患者的影响。
BMC Health Serv Res. 2020 Oct 27;20(1):977. doi: 10.1186/s12913-020-05756-8.
4
Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences.娱乐性大麻合法化对使用及危害的影响：关于性别差异的叙述性综述
Front Psychiatry. 2023 Mar 10;14:1127660. doi: 10.3389/fpsyt.2023.1127660. eCollection 2023.
5
Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.娱乐和医用大麻合法化与阿片类药物处方和死亡率。
JAMA Health Forum. 2024 Jan 5;5(1):e234897. doi: 10.1001/jamahealthforum.2023.4897.
6
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada.加拿大娱乐用大麻合法化后医用大麻使用的变化。
Cannabis Cannabinoid Res. 2024 Feb;9(1):335-342. doi: 10.1089/can.2022.0227. Epub 2023 Jan 31.
7
The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.休闲大麻商业化与向美国国家毒物数据系统报告的大麻暴露之间的关联。
Addiction. 2020 Oct;115(10):1890-1899. doi: 10.1111/add.15019. Epub 2020 Mar 10.
8
Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults.娱乐用大麻合法化改变了青少年和年轻人在大麻使用、风险认知以及大麻使用障碍治疗之间的关联。
Addict Behav. 2023 Mar;138:107552. doi: 10.1016/j.addbeh.2022.107552. Epub 2022 Nov 17.
9
Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data.医疗和娱乐用大麻合法化对酒精和香烟消费的影响变化：来自美国州税收收据数据的证据。
Int J Drug Policy. 2020 Jan;75:102585. doi: 10.1016/j.drugpo.2019.10.011. Epub 2019 Nov 15.
10
Six policy lessons relevant to cannabis legalization.与大麻合法化相关的六条政策经验教训。
Am J Drug Alcohol Abuse. 2019;45(6):698-706. doi: 10.1080/00952990.2019.1569669. Epub 2019 Mar 14.
引用本文的文献
1
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.迷幻药物的治疗潜力：应对过高期望、有力宣称、薄弱证据和巨额资金
Annu Rev Psychol. 2025 Jan;76(1):143-165. doi: 10.1146/annurev-psych-020124-023532. Epub 2024 Dec 3.
2
Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?制定有效的迷幻剂监管政策：从大麻案例中能学到什么？
Addiction. 2025 Feb;120(2):201-206. doi: 10.1111/add.16575. Epub 2024 Jun 6.
3
State Cannabis Legalization and Psychosis-Related Health Care Utilization.州层面的大麻合法化与精神病相关的医疗保健利用。
JAMA Netw Open. 2023 Jan 3;6(1):e2252689. doi: 10.1001/jamanetworkopen.2022.52689.
4
Evaluation of State Cannabis Laws and Rates of Self-harm and Assault.评估州级大麻法律与自残和袭击率的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211955. doi: 10.1001/jamanetworkopen.2021.1955.
5
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.州政策允许将医用大麻用于阿片类药物使用障碍与该适应症的药房营销之间的关联。
JAMA Netw Open. 2020 Jul 1;3(7):e2010001. doi: 10.1001/jamanetworkopen.2020.10001.
本文引用的文献
1
Assessing the public health impacts of legalizing recreational cannabis use: the US experience.评估休闲用大麻合法化对公众健康的影响：美国的经验。
World Psychiatry. 2020 Jun;19(2):179-186. doi: 10.1002/wps.20735.
2
Association between medical cannabis laws and opioid overdose mortality has reversed over time.医疗大麻法律与阿片类药物过量死亡率之间的关联随时间发生了逆转。
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12624-12626. doi: 10.1073/pnas.1903434116. Epub 2019 Jun 10.
3
Six policy lessons relevant to cannabis legalization.与大麻合法化相关的六条政策经验教训。
Am J Drug Alcohol Abuse. 2019;45(6):698-706. doi: 10.1080/00952990.2019.1569669. Epub 2019 Mar 14.
4
Should Physicians Recommend Replacing Opioids With Cannabis?医生应该建议用大麻替代阿片类药物吗？
JAMA. 2019 Feb 19;321(7):639-640. doi: 10.1001/jama.2019.0077.
5
Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use.关于孕早期使用大麻的大麻药房推荐。
Obstet Gynecol. 2018 Jun;131(6):1031-1038. doi: 10.1097/AOG.0000000000002619.
6
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products.食用医用大麻产品中大麻素剂量与标签准确性
JAMA. 2015;313(24):2491-3. doi: 10.1001/jama.2015.6613.
7
Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants.2001-2007 年在加利福尼亚州寻求医用大麻的长期大麻使用者（2001-2007 年）：4117 名申请人的人口统计学、社会特征、大麻和其他药物使用模式。
Harm Reduct J. 2007 Nov 3;4:16. doi: 10.1186/1477-7517-4-16.
Zotero 插件